tocilizumab
Showing 1 - 25 of 243
Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)
Recruiting
- Tocilizumab
- Thyroid Associated Ophthalmopathy
- Tocilizumab
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Oct 11, 2023
Malignant Pleural Effusion, Malignant Ascites Trial in Pittsburgh (Tocilizumab)
Not yet recruiting
- Malignant Pleural Effusion
- Malignant Ascites
- Tocilizumab
-
Pittsburgh, PennsylvaniaAllegheny Health Network Cancer Institute
Aug 30, 2023
Aneurysm, Behcet Syndrome, Vascular Type Trial in Beijing (tocilizumab, tofacitinib, cyclophosphamide)
Not yet recruiting
- Aneurysm
- Behcet Syndrome, Vascular Type
- tocilizumab
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 26, 2023
Sickle Cell Disease, Acute Chest Syndrome Trial (Tocilizumab)
Not yet recruiting
- Sickle Cell Disease
- Acute Chest Syndrome
- Tocilizumab
- (no location specified)
Nov 28, 2022
Multiple Myeloma Trial in Suzhou (Tocilizumab)
Recruiting
- Multiple Myeloma
- Tocilizumab
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
May 3, 2023
A Time to Cardiovascular Event Analysis Comparing Tocilizumab to
Completed
- Rheumatoid Arthritis
- Other Biologics
- Tocilizumab
- (no location specified)
Jan 20, 2023
Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)
Active, not recruiting
- Hematologic Malignancy
- Tacrolimus
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital
Jan 31, 2023
Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Carboplatin
- Tocilizumab
-
Carmel, Indiana
- +2 more
Apr 27, 2023
Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Tocilizumab
-
Nantes, FranceCHU of Nantes
Dec 16, 2022
Tocilizumab Versus Tocilizumab/Infliximab in COVID-19-associated
Completed
- Covid19
- +2 more
- Tocilizumab
- Infliximab
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Breast Cancer Trial in Fayoum (Tocilizumab, traditional Covid -19 therapy)
Completed
- Breast Cancer
- Tocilizumab
- traditional Covid -19 therapy
-
Fayoum, EgyptALsafwa specialized hospital
Oct 31, 2022
COVID-19 Trial in Chicago (Tocilizumab, Standard of Care)
Recruiting
- COVID-19
- Tocilizumab
- Standard of Care
-
Chicago, IllinoisUniversity of Chicago Medicine
May 11, 2022
COVID-19 Trial in Chicago (Tocilizumab)
Completed
- COVID-19
- Tocilizumab
-
Chicago, IllinoisUniversity of Chicago Medicine
May 13, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Tocilizumab
- Venetoclax
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 24, 2023
Lung Transplant Trial in Canada, United States (Tocilizumab, Placebo for Tocilizumab)
Not yet recruiting
- Lung Transplant
- Tocilizumab
- Placebo for Tocilizumab
-
Phoenix, Arizona
- +16 more
Sep 8, 2023
Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)
Not yet recruiting
- Juvenile Idiopathic Arthritis
- Upadacitinib
- Tocilizumab
- (no location specified)
Nov 7, 2022
Coronary Artery Disease, Aortic Valve Disease Trial in Copenhagen (Tocilizumab, Isotonic sodium chloride (0.9%), Dexamethasone
Recruiting
- Coronary Artery Disease
- Aortic Valve Disease
- Tocilizumab
- +8 more
-
Copenhagen, DenmarkThe Heart Centre, Rigshospitalet
Nov 29, 2022
COVID-19 Trial in Patras (Tocilizumab, Baricitinib)
Recruiting
- COVID-19
- Tocilizumab
- Baricitinib
-
Patras, GreeceUniversity Hospital of Patras, Department of Respiratory Medicin
Apr 5, 2022
Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)
Withdrawn
- Hemophagocytic Lymphohistiocytosis
- tocilizumab
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 11, 2022
Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome), Virus Diseases Trial in Cayenne (Tocilizumab, Dexamethasone)
Completed
- Coronavirus Infection
- +7 more
- Tocilizumab
- Dexamethasone
-
Cayenne, French GuianaCH Andrée Rosemon
Jun 7, 2022
Pancreatic Cancer Trial in Herlev (Nivolumab, Ipilimumab, Tocilizumab)
Terminated
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Herlev, DenmarkHerlev & Gentofte University Hospital, Denmark
Mar 15, 2022
COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml
Recruiting
- COVID-19 Severe Respiratory Failure
- Dexamethasone
- +5 more
-
Alexandroupolis, Evros, GreeceUniversity Hospital of Alexandroupolis
Mar 11, 2022
Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)
Active, not recruiting
- Unresectable Pancreatic Carcinoma
- Tocilizumab
- +2 more
-
Herlev, Denmark
- +1 more
Mar 15, 2022
Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)
Active, not recruiting
- Leukemia
- Alemtuzumab
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 2, 2022